Literature DB >> 299766

Identification of a B-cell surface structure involved in antigen-dependent triggering: absence of this structure on B cells from CBA/N mutant mice.

B Huber, R K Gershon, H Cantor.   

Abstract

CBA/N mice have an X-linked B-cell maturation defect which is reflected in part in an absence or dysfunction of a subclass of mature B cells. We have immunized the defective male offspring of the mating (CBA/N female X BALB/c male) with BALB/c spleen cells. The resulting antiserum (alphaLyb3) selectively reacts with a component on the surface of a portion of B cells from a panel of H-2 different mouse strains. Binding of alphaLyb3 serum to this B-cell subclass results in substantial (10- to 20-fold) enhancement of the antibody response to low doses of SRBC. Both binding and enhancing activity are removed by absorption with B cells from B6 and BALB/c, but not CBA/N mice. Absorption of the serum with bone marrow cells, T cells, or thymocytes from Lyb3+ strains does not remove activity. Since the enhanced plaque-forming cell (PFC) responses are specific for the immunizing antigen, and since no PFC response is produced by injection of the antiserum alone, this enhancement probably reflects a second signal produced by specific interaction between antibody and the surface Lyb3 component. Moreover, this signal can partially replace the requirement for T cells in the production of antibody to a "thymus-dependent" antigen. These findings (taken in conjunction with the previously described immune defects in CBA/N mice and other studies of B-cell maturation) suggest to us that Lyb3 is a cell surface component expressed selectively on a mature B-cell subclass. This component is important in B-cell triggering by antigen and fails to develop in CBA/N mice, due to a dysfunction of a regulatory gene on the CBA/N X chromosome.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 299766      PMCID: PMC2180590          DOI: 10.1084/jem.145.1.10

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  9 in total

1.  Specific purification of lymphocyte populations on a digestible immunoabsorbent.

Authors:  S F Schlossman; L Hudson
Journal:  J Immunol       Date:  1973-01       Impact factor: 5.422

2.  The genetics of the immune response to a synthetic double-stranded RNA in a mutant CBA mouse strain.

Authors:  I Scher; M M Frantz; A D Steinberg
Journal:  J Immunol       Date:  1973-05       Impact factor: 5.422

3.  In vitro studies of the genetically determined unresponsiveness to thymus-independent antigens in CBA/N mice.

Authors:  P L Cohen; I Scher; D E Mosier
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

4.  X-linked B-lymphocyte immune defect in CBA/N mice. II. Studies of the mechanisms underlying the immune defect.

Authors:  I Scher; A D Steinberg; A K Berning; W E Paul
Journal:  J Exp Med       Date:  1975-09-01       Impact factor: 14.307

5.  X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells.

Authors:  I Scher; A Ahmed; D M Strong; A D Steinberg; W E Paul
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

6.  Ontogeny of B-lymphocyte function. I. Restricted heterogeneity of the antibody response of B lymphocytes from neonatal and fetal mice.

Authors:  E A Goidl; G W Siskind
Journal:  J Exp Med       Date:  1974-11-01       Impact factor: 14.307

7.  Abnormal ratio of membrane immunoglobulin classes in mice with an X-linked B-lymphocyte defect.

Authors:  F D Finkelman; A H Smith; I Scher; W E Paul
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

8.  Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses.

Authors:  B Huber; H Cantor; F W Shen; E A Boyse
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

9.  Genetic control of the antibody response to type 3 pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness.

Authors:  D F Amsbaugh; C T Hansen; B Prescott; P W Stashak; D R Barthold; P J Baker
Journal:  J Exp Med       Date:  1972-10-01       Impact factor: 14.307

  9 in total
  36 in total

Review 1.  Functional B-lymphocyte surface antigens.

Authors:  J T Golay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

2.  Dissociation of murine B-cell proliferation and differentiation by monoclonal antibody, NIM R2.

Authors:  S Marshall-Clarke; J Harrison; R M Parkhouse
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

3.  Localization of spontaneously hyperactive B cells of NZB mice to a specific B cell subset.

Authors:  P B Nakajima; S K Datta; R S Schwartz; B T Huber
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Two B-cell subpopulations identified by flow cytometry.

Authors:  J R Watkins; M R Loken; K L Knight
Journal:  Immunology       Date:  1985-10       Impact factor: 7.397

5.  Antigenic similarities of rat and mouse IgG subclasses associated with anti-carbohydrate specificities.

Authors:  M Nahm; G P Der-Balian; D Venturini; H Bazin; J M Davie
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

6.  Capacity to interact with T-cell replacing factor correlates with acquisition by B cells of murine differentiation antigen-1.

Authors:  J R Battisto; J H Finke; B Yen
Journal:  Immunology       Date:  1979-07       Impact factor: 7.397

7.  An alloantigen selective for B cells: Ly-17.1.

Authors:  F W Shen; E A Boyse
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

8.  Structural analysis of a new B-cell-differentiation antigen associated with products of the I-A subregion of the H-2 complex.

Authors:  B T Huber; P P Jones; D Thorley-Lawson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

9.  Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA.

Authors:  B J Steinberg; P A Smathers; K Frederiksen; A D Steinberg
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

10.  Potentiation of a primary in vivo antibody response by alloantisera against gene products of the I region of the H-2 complex.

Authors:  M Pierres; R N Germain; M E Dorf; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.